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Salt-Regulating Hormones in Young
Normotensive Obese Subjects
Effects of Saline Load
Giuseppe Licata, Massimo Volpe, Rosario Scaglione, Speranza Rubattu
Abstract To investigate whether the response of salt-regu-
lating hormones to volume expansion is impaired in obese
subjects, we assessed the effects of saline load (0.25 mlV
kg • min • 120 min) in 9 young, healthy, normotensive obese
subjects (body mass index, >30 kg/m2) and in 10 lean control
subjects (body mass index, <25 kg/m2) matched for age,
gender, height, and mean blood pressure. Hematocrit, plasma
renin activity (PRA), plasma aldosterone (PA), atrial natri-
uretic factor (ANF), and urinary sodium excretion (Un,V)
were evaluated. Saline load increased ANF levels significantly
(P<.001) in lean subjects at both 60 and 120 minutes, whereas
they decreased in obese subjects. Such decreases became
significant (P<.01) at 120 minutes. Suppression of PRA and
PA by saline load were more marked in lean than obese
subjects. Hematocrit decreased in both groups, and UNlV
increased more in lean than obese subjects during saline load.
Comparisons of percent changes in ANF, PRA, and PA after
saline load showed that the responses of lean and obese
subjects were significantly different (P<.001 for ANF at both
60 and 120 minutes; P<.05 for PRA and PA at both 60 and 120
minutes). In conclusion, the lack of ANF response and the
reduced suppression of PRA and PA to saline load indicate a
dysfunction of these systems in obese subjects. This alteration
may be involved in the higher susceptibility of obese subjects
to developing hypertension. (Hypertension. 1994;23 [suppl
I]:I-20-I-24.)
Key Words • renin-angiotensin system • obesity •
atrial natriuretic factor • hypertension, sodium-dependent
A lthough a strong association between obesity and
/ \ high blood pressure has been well characterized,
A. ^ the physiological basis of obesity-induced hyper-
tension is still unclear.1-2 Several abnormalities recently
have been associated with the mechanisms involved in
obesity-related hypertension. They include sodium reten-
tion,3 increased plasma volume and cardiac output,4 hy-
perinsulinemia and insulin resistance,5 and enhanced sym-
pathetic nervous system activity.6 Conflicting findings have
been reported on plasma renin activity (PRA) and plasma
aldosterone (PA) behavior in normotensive and hyperten-
sive obese subjects.79 In addition, few studies have ad-
dressed the significance of atrial natriuretic factor (ANF)
in obesity-related hypertension.10
The relations among these factors in obese subjects
might be of great importance because the renin-angioten-
sin-aldosterone system (RAAS) has been recognized as
one of the fundamental control systems of salt, water, and
blood pressure homeostasis.11 In addition, RAAS dysreg-
ulation has been reported in subsets of hypertensive
patients, such as "salt-sensitive non-modulators,"12 and it
may be involved in obesity-related hypertension. In fact,
previous studies have indicated that obese adolescents3
and fat-fed dogs13 exhibit an enhanced blood pressure
sensitivity to salt intake. Moreover, recent experimental
data suggest that the regulatory mechanisms controlling
sodium excretion and extracellular fluid volume are al-
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tered in dogs with obesity-induced hypertension.2-14 The
ANF response to volume expansion is also a sensitive
marker of the adaptive ability of the cardiovascular system
to increased preload.15
In this study, the responses of PRA, ANF, and PA to
volume expansion by saline load were investigated in
young normotensive lean and obese subjects. Our final
goal was to recognize early alterations of factors con-
trolling sodium balance that could explain the higher
susceptibility of obese subjects to developing hyperten-
sion. Because obesity is often associated with metabolic
or cardiovascular abnormalities, we selected obese sub-
jects without hypertension, lipid abnormalities, or insu-
lin-dependent or -independent diabetes mellitus.
Methods
Subjects
A total of 19 subjects, 9 obese and 10 lean healthy subjects,
were included in the study. Obese subjects were recruited from
the obese population younger than 45 years attending the
obesity center of the Internal Medicine Department at the
University of Palermo (Italy). According to body mass index
(BMI) values and the criteria of Garrow and Webster,16
subjects were divided into two groups: The lean group con-
sisted of 10 subjects (5 men and 5 women), aged 28 to 44 years
(mean, 4O.5±3.5 years) with a BMI less than 25 kg/m2 (mean,
24.2±1.5); the obese group consisted of 9 subjects (4 men and
5 women), aged 27 to 42 years (mean, 35.3 ±4.5 years) with a
BMI greater than or equal to 30 kg/m2 (mean, 39±2).
Exclusion criteria were insulin-dependent or -independent
diabetes mellitus, hyperlipoproteinemia, endocrine and car-
diovascular diseases, hypertension, positive family history of
hypertension or cardiovascular accidents, alcoholism, drug
addition, and psychiatric problems.
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All obese and lean subjects were normotensive and matched
as closely as possible with regard to age, gender, body height,
systolic blood pressure (SBP), diastolic blood pressure (DBP),
and mean blood pressure (Table 1). SBP and DBP were
obtained from the average of three measurements made with
a mercury sphygmomanometer after subjects had been in a
comfortable supine position for 5 minutes. DBP refers to
Korotkoff phase V. Mean blood pressure was calculated from
the sum of DBP plus one third of the arterial pulse pressure.
Arterial pressure was measured with an appropriately sized
cuff in obese subjects.17
Resting heart rate was obtained from electrocardiogram.
Cardiovascular diseases were excluded on the basis of absence
of chest pain or previous myocardial infarction and of appro-
priate investigations including chest radiograph, basal and
24-hour electrocardiograph monitoring, and M- and B-mode
echocardiography. Echocardiographic left ventricular mass
and left ventricular mass index were calculated according to
the criteria of Devereux et al.18 All subjects with unsatisfactory
echocardiographic findings or with left ventricular hypertrophy
were excluded. All obese subjects were untreated for at least 4
weeks before the study, and they maintained a normal diet.
The present study was approved by the Ethics Committee of
our institution, and each patient gave informed consent after a
detailed description of the study procedure.
Experimental Protocol
All drug therapy was discontinued at least 4 weeks before
the study. Alcohol, caffeine, cigarettes, and physical exercise
were all prohibited within 24 hours of the study. After
admission to the clinical ward, all subjects were maintained on
a daily diet containing 100 mEq sodium, 50 mEq potassium,
and 1500 mL water. Daily 24-hour urine collections were
analyzed for sodium, potassium, and creatinine excretions.
When subjects had achieved metabolic balance, as assessed by
the stability of urinary electrolyte excretion, the studies were
undertaken.
The study was begun at 7:30 AM with the subject in a
comfortable seated position after voiding. The temperature
(22°C) and lights of the study room were maintained constant.
The patient was asked to drink 500 mL of water to ensure
sufficient urinary flow.
Thirty minutes after insertion of two intravenous lines into
superficial forearm veins, 20-minute baseline clearance peri-
ods were performed. Throughout the study, at the end of each
period the patients drank an amount of water equivalent to the
sum of blood loss and urinary flow. As soon as balance was
achieved (consistent urinary volumes in two consecutive clear-
ance periods), two 30-minute baseline periods were observed,
and the average of the urinary and hormonal measurements
obtained during the two baseline periods was used for analysis.
Subsequently, an intravenous isotonk saline load (0.9% NaCl,
0.25 mL/kg per minute) was started and maintained at a constant
rate for 2 hours. Arterial blood pressure was measured at
10-minute intervals, and heart rate was continuously monitored
by electrocardiogram. Urinary samples for determination of
volume, sodium, and potassium were obtained at the end of each
clearance period. Venous blood samples for determination of
hematocrit, PRA, PA, and immunoreactive ANF levels were
obtained at 30-minute intervals.
Laboratory Methods
All blood samples were collected on ice; plasma was then
separated and frozen until the time of the assay, which did not
exceed 5 weeks. PRA was measured by radioimmunoassay
according to the method described by Menard and Catt.19
Plasma ANF levels were determined by radioinununoassay as
previously described by Volpe et al20 using rabbit antiserum
(RAS 8798, Peninsula Laboratories Europe), iodinated human
ANF (2000 Ci/mmol, Amersham, Berks, UK), and o-human
ANF (Bissendorf GmbH Peptide) as a standard. ANF was
extracted from plasma with Sep-Pak C18 cartridges. Recover-
ies were determined on each plasma sample by adding to it a
minimal amount of radiolabeled ANF, ranging from 74% to
90%. Intra-assay and interassay coefficients of variation were
6.5% and 10.5%, respectively. The radioimmunoassay sensi-
tivity was 1 fmol per tube. PA concentrations were estimated
by a radioimmunoassay method using a commercial kit (Sorin,
Saluggia, Italy). Plasma insulin levels were also determined at
baseline by a radioimmunoassay double-antibody method us-
ing a commercial kit (Sorin). Intra-assay variation was 7.5%,
and interassay variation was 8%; sensitivity for detection of
insulin was 2.5 ^.U/mL. Urinary potassium and sodium levels
were measured by a current ion-selective electrode method
(Beckman).
Statistical Analysis
Data are presented as mean±SD. Comparisons of the basal
data of lean and obese subjects were performed by unpaired t
test. Analysis of variance with Dunnett's correction was used
to determine significant differences within the same group.
Between-group comparisons of the responses to saline load
were tested by two-factor analysis of variance (factoring for
group and time) for repeated measures.
Results
Characteristics of Lean and Obese Subjects
The two groups of subjects were comparable with
regard to clinical and metabolic baseline characteristics.
In fact, no significant differences in age, height, blood
pressure, heart rate, left ventricular mass index, serum
TABLE 1. Characteristics of the Study Groups
Characteristic
Age, y
Sex, M/F
Weight, kg
Height, cm
BMI, kg/m2
SBP, mm Hg
DBP, mm Hg
HR, bpm
LVMI, g/m2
Glucose, mmol/L
Serum creatinine, ^mol/L
Total cholesterol, mmol/L
UN,V, mmol/24 h
PRA, ng/mL/h
PA, pg/mL
ANF, pg/mL
IRI, MU/mL
Lean
(n=10)
37.5±3.5
5/5
67.8±3
165±4
24.2 ±1.5
127±4
82±3
76.2±3.1
106±12
5.0±0.02
76±8.8
4.9±0.3
127±16
2.3±0.5
296±50
26±7
9.1 ±3.2
Obese
(n=9)
35.3±4.5
4/5
104±7
163±5
39±2
125±5
84±6
78.2±7
96±10
5.1 ±0.02
79.6±8.8
5±0.3
130±10
3.1 ±0.6
276 ±24
29±11
14.6±3.7
P
NS
<.00O1
NS
<.0O01
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
<.O5
BMI indicates body mass index; SBP, systolic blood pressure;
DBP, diastolic blood pressure; HR, heart rate; bpm, beats per
minute; LVMI, echocardiographic left ventricular mass index;
UN,V, urinary sodium excretion rate; PRA, plasma renin activity;
PA, plasma aldosterone; ANF, atrlal natriuretic factor; and IRI,
serum immunoreactive insulin.
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Line graphs show responses of atrial natriuretic factor (ANF), plasma renin activity (PRA), and plasma aldosterone (PA) to saline load
In young normotenslve lean and obese subjects. *P<.001, **P<.01 vs baseline.
glucose, total cholesterol, and creatinine were observed.
Baseline PRA, PA, ANF, and urinary sodium excretion
rate were similar in the two groups. Insulin levels were
significantly (P<.05) higher in obese compared with
lean subjects (Table 1).
Hormonal Responses to Saline Load
In lean subjects saline load was associated with a
progressive increase in plasma ANF levels (from 26 ±7
to 72±10 and 87±11 pg/mL at 60 and 120 minutes,
respectively), which became significant (P<.001) at 60
minutes, whereas PRA (P<.001) and PA (P<.001) were
progressively reduced (PRA, from 2.3±0.5 to 0.9±0.2
and 0.7±0.1 ng/mL per hour; PA, from 296+50 to
170±16 and 126±18 pg/mL) (Figure, left panel). Uri-
nary sodium excretion rate (/><.OO1) increased signifi-
cantly after 60 and 120 minutes (Table 2).
As shown in the Figure (right panel), in the obese
subjects ANF levels did not increase and were slightly
reduced in response to saline loading (from 29±11 to
24±9 and 22±6 pg/mL); this reduction was significant
(P<.01) at 120 minutes. PRA and PA values were
suppressed by a saline load (PRA, from 3.1 ±0.6 to
2.6±0.3 and 2.4±0.6 ng/mL per hour; PA, from
276±24 to 244±18 and 222±13 pg/mL) in the obese
subjects to a lesser extent than in the lean subjects;
these values became significant (both P<.0\) only at
120 minutes. Saline load also increased urinary so-
dium excretion rate in obese subjects but was signifi-
cant (/><.O1) only at 120 minutes (Table 2).
A mild but not significant increase in SBP and DBP
was observed in both groups at both experimental times.
This increase was similar in lean and obese subjects
(Table 2). Comparisons of percent changes in ANF,
PRA, and PA after saline load show that the responses
of lean and obese subjects were significantly different
(i><.001 for ANF at both 60 and 120 minutes; P<.05 for
PRA and PA at both 60 and 120 minutes). Finally,
volume expansion induced comparable reductions of
hematocrit in the two groups from 0.42±0.2 to 0.40±0.2
and 0.39±0.2 in lean subjects, and from 0.45±0.4 to
0.43+0.5 and 0.41±0.5 in obese subjects.
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TABLE 2. Effects of Saline Load on Urinary Sodium
Excretion and Systolic and Dlastollc Blood Pressures In
Lean and Obese Subjects
Baseline 60 Minutes 120 Minutes
Lean sub|ects (n=10)
UN.V, mmol/min 112±8 504±51* 816±64*
SBP, mmHg 127±4 128±3 129±2
DBP, mm Hg 82±3 84±2 84±3
Obese subjects (n=9)
UN.V, mmol/mln 148±56 265±105 680±210t
SBP, mmHg 125±5 128±4 129±2
DBP, mmHg 84±6 86±3 86±3
UN,V indicates urinary sodium excretion rate; SBP, systolic
blood pressure; and DBP, dlastolic blood pressure.
*P<.001, tf<.01 vs baseline.
Discussion
Our study demonstrates remarkable differences in
the hormonal responses to an acute saline load be-
tween young normotensive lean and obese subjects.
More specifically, in the obese subjects the major
physiological adjustments occurring in response to an
acute saline load, ie, suppression of PRA and PA
levels and increased urinary sodium excretion values,
were significantly smaller or delayed compared with
those reported in lean subjects. The physiological
secretory response of ANF promoted by saline load in
lean subjects was not detectable in obese subjects. In
fact, ANF levels were slightly reduced at both 60 and
120 minutes of saline load in young normotensive
obese subjects.
It seems unlikely that these differences may have
been accounted for by a different baseline degree of
volume depletion because both groups were main-
tained on the same intake of fluids and sodium. In
addition, volume expansion was similar in both groups,
as documented by the induced changes in hematocrit
values. Similarly, the abnormal responses observed in
the obese subjects cannot be related to concomitant
alterations often associated with obesity, ie, hyperten-
sion, diabetes, or lipid abnormalities because the
obese subjects selected for this study were not affected
by these concomitant diseases. The abnormal hor-
monal responses to saline load may be related to the
higher susceptibility of obese subjects to developing
hypertension. In fact, hyposecretion of ANF in re-
sponse to a saline load has been reported in different
rat models of genetic hypertension, including stroke-
prone spontaneously hypertensive rats.21 In addition, a
smaller suppression in renin and PA levels after saline
load has been recently reported by West et al13 in
hypertensive obese dogs compared with lean dogs.
Several experimental data suggest that activation of
sodium-retaining systems during obesity, such as the
RAAS and plasma insulin levels, could be involved in
obesity-induced hypertension.1315 These parameters
may be altered in obese animals and humans, but only
some indirect information is available on ANF levels in
obesity.10'22
In particular, increased insulin levels and insulin
resistance have been recognized in both normotensive
and hypertensive obese subjects3-6'14-22 and have been
associated with obesity-induced hypertension in view of
the effects of insulin on the kidney, the cardiovascular
system, and the cellular mechanisms of sodium trans-
port. In fact, insulin can promote sodium retention
through an increased sodium reabsorption by the prox-
imal tubule.23-24 This action, if prolonged, could deter-
mine extracellular volume expansion involving salt-reg-
ulating hormonal systems. On the other hand, insulin
could promote sodium retention through increased an-
giotensin-induced aldosterone production,25 enhanced
sympathoadrenergic activity,5'6 or reduction in ANF
release.10
The hormonal responses reported in our obese sub-
jects were reduced and delayed compared with those
observed in lean subjects. These abnormal hormonal
responses may be involved in the sodium sensitivity
described in obese individuals.3-7'22 Further studies will
be required to test whether the dysregulation in ANF
and the RAAS may be involved in the higher suscepti-
bility of obese subjects to hypertension and cardiovas-
cular risk.
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